doi: 10.1146/annurev-med-060513-093205 11 MaynardCLElsonCOHattonRDWeaverCT
In 2025, major US retailers expanded shelf placement for high-protein GLP-1 companion nutrition products as consumers sought convenient solutions supporting protein intake, satiety management, and daily nutritional adequacy during weight-management therapy routines, supporting GLP-1 supplement market growth
Some diabetes medications, blood pressure drugs, or psychiatric medications may interact with GLP-1 compounds
Another factor that we considered in our current proposal is the experience hospitals have gained through the process of disclosing the payer-specific negotiated charge information for the purpose of the hospital price transparency requirements
Data availability All data and reagents will be made available upon request
What Causes Low Ceruloplasmin